FDA Brief

Warning letters Food

FDA warning letter to

Naturally Infused LLC

High riskIssued Nov 16, 2022Posted Nov 21, 2022Center for Food Safety and Applied Nutrition (CFSAN)

Naturally Infused LLC sells CBD and Delta-8 THC foods and drugs with unapproved claims, making them adulterated and misbranded.

What happened

FDA reviewed www.naturallyinfused.com in October 2022 and the company's Instagram and Facebook pages, which direct consumers to the website, and found orders for human and animal products represented as containing CBD or Delta-8 THC. FDA also collected and analyzed samples of CBD Lollipops and CBD Infused Sugar, confirmed cannabinoids, and noted the purchased CBD Lollipops had no label saying they contain CBD.

What FDA found

  1. CBD added to the lollipops, sugar, gummies, and coffees is an unsafe food additive, so those foods are adulterated (contain an unsafe ingredient).

    FD&C Act section 402(a)(2)(C)(i), 21 U.S.C. 342(a)(2)(C)(i)
  2. Delta-8 THC added to the coffees and gummies is an unsafe food additive, so those foods are adulterated.

    FD&C Act section 402(a)(2)(C)(i), 21 U.S.C. 342(a)(2)(C)(i)
  3. Introducing the CBD foods into interstate commerce is prohibited because CBD is an approved drug ingredient or subject to public clinical investigations.

    FD&C Act section 301(ll), 21 U.S.C. 331(ll)
  4. Website and social media claims that CBD products treat epilepsy, bipolar disorder, cancer, and other conditions make them unapproved new drugs (not FDA-approved).

    FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)
  5. The CBD products for humans are misbranded (labeling is inadequate) because their labels lack adequate directions for use.

    FD&C Act section 502(f)(1), 21 U.S.C. 352(f)(1)

What FDA wants

FDA asks the company to notify it in writing within 15 working days of the specific steps taken to address the violations, including an explanation and related documentation. If it cannot complete corrective actions in that time, it must give the reason and a completion date, and if it believes there is no violation, it must include its reasoning and supporting information.

Who should pay attention

  • retailers selling CBD or Delta-8 THC edibles
  • brands that buy CBD foods from contract manufacturers
  • companies making disease claims for CBD or animal CBD products

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Trew Balance

    FDA warned Trew Balance that its Trew Vision CBD Eye Drops are an unapproved new drug sold with disease-treatment claims.

    High risk
  2. Bailey’s Wellness, LLC dba Bailey’s CBD

    Bailey’s CBD markets CBD animal and human products with unapproved drug claims, including products for food-producing animals.

    High risk
  3. House of Alchemy LLC dba CBD Dog Health Hamet & Love LLC dba MycoDog

    FDA warned CBD Dog Health and MycoDog their CBD and mushroom pet products are unapproved animal drugs, citing disease-treatment claims online.

    High risk
  4. Holista LLC dba HolistaPet

    FDA warned HolistaPet that its CBD animal products are unapproved new animal drugs and adulterated animal food.

    High risk